Status:

WITHDRAWN

ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients

Lead Sponsor:

NeuroDx Development

Collaborating Sponsors:

Johns Hopkins University

Conditions:

Normal Pressure Hydrocephalus

Eligibility:

All Genders

35-90 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to examine the role of ShuntCheck and MR Imaging in evaluating the presence or absence of Shunt Obstruction in the patients of Hydrocephalus or Idiopathic Intracranial Hyp...

Detailed Description

This study aims to correlate findings of ShuntCheck and MRI with the Radionuclide patency study. Patients will be enrolled if they have Hydrocephalus or IIH, present with symptoms of shunt obstruction...

Eligibility Criteria

Inclusion

  • Adult Patients \> 35 years capable and willing to consent for their participation or consent obtained from a legal guardian.
  • Patients with an indwelling shunt and clinical assessment strongly suggestive of shunt obstruction
  • Patients are candidates for shunt patency procedures in the elective extension

Exclusion

  • Patients \<35 years of age
  • Patients with symptoms attributable to valve malfunction or shunt infection
  • Patients who need urgent shunt replacement and therefore cannot wait for the SHUNTCHECK evaluation of shunt patency.
  • Patients with edema or wound of skin overlying the shunt tissue.
  • Patients not capable or not willing to consent to participate in the study

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00793416

Start Date

November 1 2008

End Date

August 1 2012

Last Update

October 29 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Johns Hopkins Medical Center

Baltimore, Maryland, United States, 21287